What's Going On With Redhill Biopharma Stock On Tuesday?

Redhill Biopharma Ltd (NASDAQ:RDHL) stock is trading lower on Tuesday, possibly on profit-taking after the stock rallied roughly 36% on Monday, as per data from Benzinga Pro.On Monday, RedHill Biopharma shared development progress for RHB-102 (Bekinda) in multiple gastrointestinal (GI) indications, including its development, via the accelerated FDA 505(b)(2) route, as a once-daily oral ondansetron therapy for GLP-1/GIP receptor agonist therapy-associated GI side effects.RHB-102 is a patent-protected bimodal ...